0
 

LivaNova PLC-Company profile, Business Overview, Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report

  • ID: CPS__175998
  • July 2017
  • 8 pages
  • Price: $ 95
 
 

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). 

 

TOC

1.1 Company Overview

1.2 Company Snapshot

1.3 Operating Business Segment

1.4 Business Performance

1.5 Key Strategic moves and Development

 

LIST OF TABLES AND FIGURES

TABLE 1. LIVANOVA: COMPANY SNAPSHOT

TABLE 2. LIVANOVA: OPERATING SEGMENTS

FIG. 1. LIVANOVA: NET SALES, 20132015 ($MILLION)

FIG. 2. LIVANOVA: REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 3. LIVANOVA: REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 4. LIVANOVA: REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 5. LIVANOVA: SWOT ANALYSIS

Purchase Options

 

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers